Ranbaxy in strategic alliance with Orchid Chemicals

The country’s largest drug maker, Ranbaxy Laboratories, has entered into strategic business alliance with the Chennai-based Orchid Chemicals. The pact involves multiple geographies and therapies for both finished dosage forms and active pharmaceutical ingredients (API) for several products. This alliance will give Ranbaxy access to Orchid’s product range, including cepholosporins and will allow Orchid to leverage Ranbaxy’s distribution network. The agreement will pave way for future co-operation between the two companies. The companies however refused to divulge details of the deal. The agreement will be mutually beneficial and synergistic, allowing both the companies to leverage each others’ inherent strengths.